Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	15.12B
Revenue (ttm)	4.23B
Net Income (ttm)	1.06B
Shares Out	84.72M
EPS (ttm)	12.53
PE Ratio	14.25
Forward PE	12.74
Dividend	7.50 (4.17%)
Ex-Dividend Date	Mar 26, 2025

Volume	116,915
Average Volume	188,314
Open	182.00
Previous Close	180.00
Day's Range	178.50 - 183.50
52-Week Range	158.50 - 268.50
Beta	0.75
RSI	40.88
Earnings Date	May 9, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.